Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples